Meng Lan

739 total citations
14 papers, 541 citations indexed

About

Meng Lan is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Meng Lan has authored 14 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in Meng Lan's work include Flavonoids in Medical Research (4 papers), Nanoplatforms for cancer theranostics (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Meng Lan is often cited by papers focused on Flavonoids in Medical Research (4 papers), Nanoplatforms for cancer theranostics (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Meng Lan collaborates with scholars based in China, Russia and Canada. Meng Lan's co-authors include Tiange Cai, Tengteng Zou, Yu Cai, Lihong Li, Qi Wang, Rui Yu, Zhen Chen, Fengjie Liu, Hui Zhang and Jiaming Sun and has published in prestigious journals such as Cellular and Molecular Life Sciences, Molecules and Journal of Pharmaceutical Sciences.

In The Last Decade

Meng Lan

14 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meng Lan China	12	210	173	150	93	81	14	541
Tengteng Zou China	11	181 0.9×	151 0.9×	145 1.0×	86 0.9×	78 1.0×	11	470
Suchismita Mohanty India	16	388 1.8×	211 1.2×	219 1.5×	78 0.8×	67 0.8×	25	795
Dandan Jiang China	13	240 1.1×	78 0.5×	102 0.7×	98 1.1×	56 0.7×	29	449
Lavinia Lupuţ Romania	13	203 1.0×	66 0.4×	96 0.6×	91 1.0×	109 1.3×	18	455
Songtao Dong China	12	214 1.0×	62 0.4×	87 0.6×	61 0.7×	52 0.6×	19	478
Vinod Balachandran India	12	315 1.5×	130 0.8×	66 0.4×	38 0.4×	71 0.9×	14	598
Lixia Pei China	15	311 1.5×	82 0.5×	70 0.5×	45 0.5×	52 0.6×	27	691
Liling Yue China	17	323 1.5×	61 0.4×	60 0.4×	70 0.8×	69 0.9×	30	593
Bo Ren China	10	287 1.4×	274 1.6×	130 0.9×	52 0.6×	34 0.4×	17	728

Countries citing papers authored by Meng Lan

Since Specialization

Citations

This map shows the geographic impact of Meng Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Lan more than expected).

Fields of papers citing papers by Meng Lan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Lan. The network helps show where Meng Lan may publish in the future.

Co-authorship network of co-authors of Meng Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Lan. A scholar is included among the top collaborators of Meng Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Lan. Meng Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Meng, Fansu, Tiange Cai, Jaiwoo Lee, et al.. (2024). Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple‐negative breast cancer. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 16(2). e1950–e1950. 8 indexed citations

Liu, Fengjie, Meng Lan, Lihong Li, et al.. (2022). Baicalin-loaded folic acid-modified albumin nanoparticles (FA-BSANPs/BA) induce autophagy in MCF-7 cells via ROS-mediated p38 MAPK and Akt/mTOR pathway. Cancer Nanotechnology. 13(1). 33 indexed citations

Zou, Tengteng, Meng Lan, Fengjie Liu, et al.. (2021). Emodin-loaded polymer-lipid hybrid nanoparticles enhance the sensitivity of breast cancer to doxorubicin by inhibiting epithelial–mesenchymal transition. Cancer Nanotechnology. 12(1). 11 indexed citations

Li, Lihong, Tengteng Zou, Min Liang, et al.. (2021). Screening of metabolites in the treatment of liver cancer xenografts HepG2/ADR by psoralen-loaded lipid nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 165. 337–344. 10 indexed citations

Zou, Tengteng, Wenping Lü, Yaroslav Mezhuev, et al.. (2021). A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment. European Journal of Pharmaceutics and Biopharmaceutics. 166. 30–43. 37 indexed citations

Liu, Fengjie, Lihong Li, Meng Lan, et al.. (2021). Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin‐1 Signaling. Mediators of Inflammation. 2021(1). 7785890–7785890. 13 indexed citations

Liu, Hui, Yong Zhuang, Panpan Wang, et al.. (2021). Polymeric Lipid Hybrid Nanoparticles as a Delivery System Enhance the Antitumor Effect of Emodin in Vitro and in Vivo. Journal of Pharmaceutical Sciences. 110(8). 2986–2996. 22 indexed citations

Lan, Meng, Fengjie Liu, Tengteng Zou, et al.. (2021). Activating caspase-8/Bid/ROS signaling to promote apoptosis of breast cancer cells by folate-modified albumin baicalin-loaded nanoparticles. Nanotechnology. 33(43). 435101–435101. 15 indexed citations

Lan, Meng, Wenping Lü, Tengteng Zou, et al.. (2021). Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy. Cellular and Molecular Life Sciences. 78(5). 2105–2129. 23 indexed citations

10.

Meng, Fansu, Fengjie Liu, Meng Lan, et al.. (2021). Preparation and evaluation of folate-modified albumin baicalin-loaded nanoparticles for the targeted treatment of breast cancer. Journal of Drug Delivery Science and Technology. 65. 102603–102603. 28 indexed citations

11.

Liu, Fengjie, Lihong Li, Meng Lan, et al.. (2021). Psoralen-Loaded Polymeric Lipid Nanoparticles Combined with Paclitaxel for The Treatment of Triple-Negative Breast Cancer. Nanomedicine. 16(27). 2411–2430. 12 indexed citations

12.

Li, Lihong, Rui Yu, Tiange Cai, et al.. (2020). Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment. International Immunopharmacology. 88. 106939–106939. 266 indexed citations

13.

Zhang, Ye, Meng Lan, Jing‐Feng Li, et al.. (2019). Antioxidant, Anti‐inflammatory and Cytotoxic Activities of Polyphenols Extracted from Chroogomphus rutilus. Chemistry & Biodiversity. 17(1). e1900479–e1900479. 27 indexed citations

14.

Li, Chunnan, Meng Lan, Jingwei Lv, et al.. (2019). Screening of the Hepatotoxic Components in Fructus Gardeniae and Their Effects on Rat Liver BRL-3A Cells. Molecules. 24(21). 3920–3920. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact